Literature DB >> 19914360

Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.

Yan Wang1, Lei Gao, Sze-Wah Tse, Athena Andreadis.   

Abstract

The microtubule-associated protein tau is important to normal neuronal activity in the mammalian nervous system. Aggregated tau is the major component of neurofibrillary tangles (NFTs), structures present in the brains of people affected by neurodegenerative diseases called tauopathies. Tauopathies include Alzheimer's disease (AD), frontotemporal dementia with Parkinsonism (FTDP) and the early-onset dementia observed in Down syndrome (DS; trisomy 21). Splicing misregulation of adult-specific exon 10 results in expression of abnormal ratios of tau isoforms, leading to FTDP. Positions +3 to +19 of the intron downstream of exon 10 define a hotspot: Point mutations in it result in tauopathies. All these mutations increase exon 10 inclusion except for mutation +19, which almost entirely excludes exon 10. To investigate the tau connection between DS and AD, we examined splicing factors located on chromosome 21 for their effect on tau exon 10. By co-transfections, co-immunoprecipitations and RNAi constructs, we discovered that one of them, hnRNPE3 (PCBP3), modestly activates splicing of exon 10 by interacting with its proximal downstream intron around position +19. These results, coupled with the developmental profile of hnRNPE3, suggest a pathogenic role for splicing factors on chromosome 21 in neurodegenerative diseases with tangles and create a connection between tau splicing and the early-onset dementia of Down syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914360      PMCID: PMC2815234          DOI: 10.1016/j.gene.2009.11.006

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  35 in total

1.  Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia.

Authors:  Prudence M Stanford; Claire E Shepherd; Glenda M Halliday; William S Brooks; Peter W Schofield; Henry Brodaty; Ralph N Martins; John B J Kwok; Peter R Schofield
Journal:  Brain       Date:  2003-04       Impact factor: 13.501

Review 2.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

Review 3.  The SR protein family of splicing factors: master regulators of gene expression.

Authors:  Jennifer C Long; Javier F Caceres
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

Review 4.  The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms.

Authors:  Aleksandr V Makeyev; Stephen A Liebhaber
Journal:  RNA       Date:  2002-03       Impact factor: 4.942

5.  Evidence against the overexpression of APP in Down syndrome.

Authors:  Francesca Argellati; Sara Massone; Cristina d'Abramo; Umberto M Marinari; Maria A Pronzato; Cinzia Domenicotti; Roberta Ricciarelli
Journal:  IUBMB Life       Date:  2006-02       Impact factor: 3.885

6.  Identification of 3'UTR region implicated in tau mRNA stabilization in neuronal cells.

Authors:  S Aronov; R Marx; I Ginzburg
Journal:  J Mol Neurosci       Date:  1999-04       Impact factor: 3.444

7.  Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1.

Authors:  Yingzi Wang; Junning Wang; Lei Gao; Robert Lafyatis; Stefan Stamm; Athena Andreadis
Journal:  J Biol Chem       Date:  2005-02-03       Impact factor: 5.157

8.  A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features.

Authors:  Maria Kirchhoff; Anne-Marie Bisgaard; Morten Duno; Flemming Juul Hansen; Marianne Schwartz
Journal:  Eur J Med Genet       Date:  2007-05-18       Impact factor: 2.708

Review 9.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

Review 10.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

View more
  12 in total

1.  Linking spermatid ribonucleic acid (RNA) binding protein and retrogene diversity to reproductive success.

Authors:  Karen M Chapman; Heather M Powell; Jaideep Chaudhary; John M Shelton; James A Richardson; Timothy E Richardson; F Kent Hamra
Journal:  Mol Cell Proteomics       Date:  2013-08-12       Impact factor: 5.911

2.  PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Authors:  Payal Ray; Amar Kar; Kazuo Fushimi; Necat Havlioglu; Xiaoping Chen; Jane Y Wu
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

Review 3.  Tau splicing and the intricacies of dementia.

Authors:  Athena Andreadis
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

4.  An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.

Authors:  Yan Wang; Junning Wang; Lei Gao; Stefan Stamm; Athena Andreadis
Journal:  Gene       Date:  2011-06-30       Impact factor: 3.688

Review 5.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

Review 6.  Regulation of alternative splicing of tau exon 10.

Authors:  Wei Qian; Fei Liu
Journal:  Neurosci Bull       Date:  2014-03-14       Impact factor: 5.203

7.  Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice.

Authors:  Illana Gozes
Journal:  EPMA J       Date:  2010-06-12       Impact factor: 6.543

8.  Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.

Authors:  Kathryn R Bowles; Derian A Pugh; Laura-Maria Oja; Benjamin M Jadow; Kurt Farrell; Kristen Whitney; Abhijeet Sharma; Jonathan D Cherry; Towfique Raj; Ana C Pereira; John F Crary; Alison M Goate
Journal:  Acta Neuropathol       Date:  2021-12-07       Impact factor: 17.088

9.  Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome.

Authors:  Susan M Gribble; Frances K Wiseman; Stephen Clayton; Elena Prigmore; Elizabeth Langley; Fengtang Yang; Sean Maguire; Beiyuan Fu; Diana Rajan; Olivia Sheppard; Carol Scott; Heidi Hauser; Philip J Stephens; Lucy A Stebbings; Bee Ling Ng; Tomas Fitzgerald; Michael A Quail; Ruby Banerjee; Kai Rothkamm; Victor L J Tybulewicz; Elizabeth M C Fisher; Nigel P Carter
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

10.  Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.

Authors:  Aarti Ruparelia; Frances Wiseman; Olivia Sheppard; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  J Biomed Res       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.